770 related articles for article (PubMed ID: 10097514)
1. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
2. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of xenobiotics and chemical carcinogenesis.
Lang M; Pelkonen O
IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
[TBL] [Abstract][Full Text] [Related]
4. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
6. Genetic basis of toxic reactions to drugs and chemicals.
Cascorbi I
Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
[TBL] [Abstract][Full Text] [Related]
7. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
8. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
Ozawa S
Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
[TBL] [Abstract][Full Text] [Related]
9. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Daly AK; Cholerton S; Armstrong M; Idle JR
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
[TBL] [Abstract][Full Text] [Related]
10. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of genetic polymorphisms of drug metabolism.
Meyer UA; Zanger UM
Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
Wormhoudt LW; Commandeur JN; Vermeulen NP
Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
[TBL] [Abstract][Full Text] [Related]
14. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
Pelkonen O; Raunio H; Rautio A; Lang M
IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck.
Ho T; Wei Q; Sturgis EM
Head Neck; 2007 Jul; 29(7):682-99. PubMed ID: 17274053
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
18. [Genes and enzymes of the xenobiotic-metabolizing system in cancer pathology].
Liakhovich VV; Vavilin VA; Gutkina NI; Laktionova IP; Makarova SI; Mitrofanov DV; Ostashevskiĭ VA; Chasovnikova OB
Vopr Med Khim; 1997; 43(5):330-8. PubMed ID: 9446323
[TBL] [Abstract][Full Text] [Related]
19. Metabolic polymorphisms and cancer susceptibility.
Smith G; Stanley LA; Sim E; Strange RC; Wolf CR
Cancer Surv; 1995; 25():27-65. PubMed ID: 8718512
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]